News
Elevance Health posted $418 million in profit for the fourth quarter of 2024 and earned $45 billion in revenue in the quarter. For full-year 2024, Elevance reported $175.2 billion in revenue, an ...
In its first quarter 2025 investor letter, GreensKeeper Asset Management emphasized stocks such as Elevance Health, Inc. (NYSE:ELV). Elevance Health, Inc. (NYSE:ELV) is a health benefits company ...
Elevance Health will beat its earnings guidance for the first quarter despite high Medicare Advantage costs, the company announced Thursday. The health insurer reported that while Medicare ...
Baird notes Elevance Health (ELV) pre-announced a Q1 earnings beat with adjusted EPS of $11.97 vs. $11.62 implied guide, vs. $11.32 street, vs. its $11.63. The company cites medical costs ...
In other Elevance Health news, EVP Charles Morgan Kendrick, Jr. sold 3,504 shares of Elevance Health stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $396. ...
Elevance Health's resilience in a volatile health insurance market is driven by its fee-based Commercial plans and preventive care initiatives. The company's focus on administrative services only ...
Elevance Health Stock Up 0.3 % Elevance Health stock opened at $441.02 on Tuesday. The stock has a 50 day moving average of $413.71 and a two-hundred day moving average of $411.99. Elevance Health ...
Elevance Health (NYSE:ELV) on Thursday issued its preliminary financial results for Q1 2025, projecting $9.61 of GAAP net income and $11.97 of non-GAAP net income on a diluted per share basis ...
Elevance Health ELV has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. In the table below, you'll find a summary of their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results